Background:
Neurocognitive impairment (NCI) in HIV+ patients can occur despite effective ART and has been linked to increased CD16-bearing monocytes in circulation. We evaluated monocytes (M/M) phenotypes and activation markers in HIV+ patients under ART, aiming to define the role of innate immune activation on CD4+ T cell recovery and NCI.
Methods:
Cross sectional study: 84 HIV+ patients whit actual CD4+ T cell count <350/μl (n=39, Immune failure-IF) or >500/μl (n=45,Immune success-IS) after ≥18 months of ART and with VL<50 copies/ml for at least 12 months. The two groups were matched both by age and CD4+ T cell nadir. All patients participated in blood studies and a battery of 8 neuropsychological tests (NPZ8). Peripheral M/M phenotypes (distinguished based on CD14 and CD16 surface expression on “classical” CD14++CD16-, “intermediate” CD14++CD16+ and “non classical” CD14+CD16++) as well as surface activation markers (CD163, CD11b, HLA-DR, CD38, CD69) were evaluated by flow cytometry. Statistical analyses were performed using Wilcoxon and Chi-square.
Results:
Compared to IS subjects, IF patients showed significantly lower levels of “classical”(p=0.05) and higher levels of “intermediate” monocytes (p=0.04). “Non classical” monocytes were not significantly different between groups. IF patients displayed significantly lower expression of CD163 compared to IS patients, both on total (p=0.02) and “classical” monocytes (p=0.01). Regarding the expression of CD11b, IF patients showed significantly lower levels on “classical” monocytes (p=0.05) and higher levels on “intermediate” monocytes (p=0.05) compared to IS group. No differences in the expression of HLA-DR, CD38 and CD69 on M/M were found in the two groups. NCI was observed in 20/84 patients (19 defined as ANI and 1 as MND). NCI prevalence was not different between the two groups (25.7% in IF and 22.2% in IS). There was no correlation between overall NCI and monocyte phenotypes neither expression of activation markers on M/M.
Conclusions:
A shift on M/M phenotype from the “classical” towards “intermediate” and altered expression of monocyte activation markers, CD163 and CD11b, correlate with immune failure on ART. HIV-infected subjects with NCI on ART do not have a distinct monocyte phenotype using the variable we studied.